735 related articles for article (PubMed ID: 32508220)
21. Drug-coated balloon versus uncoated percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery: 2-year results of the MDT-2113 SFA Japan randomized trial.
Iida O; Soga Y; Urasawa K; Saito S; Jaff MR; Wang H; Ookubo H; Yokoi H;
Catheter Cardiovasc Interv; 2019 Mar; 93(4):664-672. PubMed ID: 30747489
[TBL] [Abstract][Full Text] [Related]
22. Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease.
Ouriel K; Adelman MA; Rosenfield K; Scheinert D; Brodmann M; Peña C; Geraghty P; Lee A; White R; Clair DG
JACC Cardiovasc Interv; 2019 Dec; 12(24):2515-2524. PubMed ID: 31575518
[TBL] [Abstract][Full Text] [Related]
23. Balloon Angioplasty of Infrapopliteal Arteries: A Systematic Review and Proposed Algorithm for Optimal Endovascular Therapy.
Giannopoulos S; Varcoe RL; Lichtenberg M; Rundback J; Brodmann M; Zeller T; Schneider PA; Armstrong EJ
J Endovasc Ther; 2020 Aug; 27(4):547-564. PubMed ID: 32571125
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
Imran HM; Hyder ON; Soukas PA
Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
[TBL] [Abstract][Full Text] [Related]
25. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K
J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
[TBL] [Abstract][Full Text] [Related]
26. The 24-Month Results of the Lutonix Global SFA Registry: Worldwide Experience With Lutonix Drug-Coated Balloon.
Thieme M; Von Bilderling P; Paetzel C; Karnabatidis D; Perez Delgado J; Lichtenberg M;
JACC Cardiovasc Interv; 2017 Aug; 10(16):1682-1690. PubMed ID: 28780030
[TBL] [Abstract][Full Text] [Related]
27. Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial.
Iida O; Soga Y; Urasawa K; Saito S; Jaff MR; Wang H; Ookubo H; Yokoi H;
J Endovasc Ther; 2018 Feb; 25(1):109-117. PubMed ID: 29264999
[TBL] [Abstract][Full Text] [Related]
28. Drug-Coated Balloon Angioplasty in Clinical Practice for Below-the-Knee, Popliteal, and Crural Artery Lesions Causing Critical Limb Ischemia: 1-Year Results from the Spanish Luminor Registry.
Riambau V; Acín F; de Blas MJ; Alonso M; Giménez-Gaibar A;
Ann Vasc Surg; 2020 Jan; 62():387-396. PubMed ID: 31449955
[TBL] [Abstract][Full Text] [Related]
29. Critical appraisal of paclitaxel balloon angioplasty for femoral-popliteal arterial disease.
Herten M; Torsello GB; Schönefeld E; Stahlhoff S
Vasc Health Risk Manag; 2016; 12():341-56. PubMed ID: 27621646
[TBL] [Abstract][Full Text] [Related]
30. Systematic Review and Meta-analysis of Randomized Controlled Trials of Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Arteries: Role of Paclitaxel Dose and Bioavailability.
Katsanos K; Spiliopoulos S; Paraskevopoulos I; Diamantopoulos A; Karnabatidis D
J Endovasc Ther; 2016 Apr; 23(2):356-70. PubMed ID: 26823485
[TBL] [Abstract][Full Text] [Related]
31. Drug-coated balloon angioplasty for the management of recurring infrapopliteal disease in diabetic patients with critical limb ischemia.
Palena LM; Diaz-Sandoval LJ; Gomez-Jaballera E; Peypoch-Perez O; Sultato E; Brigato C; Brocco E; Manzi M
Cardiovasc Revasc Med; 2018; 19(1 Pt B):83-87. PubMed ID: 28648324
[TBL] [Abstract][Full Text] [Related]
32. Single-Center Experience With Lutonix Drug-Coated Balloons in Infrapopliteal Arteries.
Steiner S; Schmidt A; Bausback Y; Bräunlich S; Ulrich M; Banning-Eichenseer U; Scheinert D
J Endovasc Ther; 2016 Jun; 23(3):417-23. PubMed ID: 27099285
[TBL] [Abstract][Full Text] [Related]
33. Paclitaxel-Coated Balloon for the Treatment of Infrainguinal Disease: 12-Month Outcomes in the All-Comers Cohort of BIOLUX P-III Global Registry.
Tepe G; Zeller T; Moscovic M; Corpataux JM; Christensen JK; Keirse K; Nano G; Schroeder H; Binkert CA; Brodmann M
J Endovasc Ther; 2020 Apr; 27(2):304-315. PubMed ID: 31989855
[No Abstract] [Full Text] [Related]
34. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty.
Scheinert D; Duda S; Zeller T; Krankenberg H; Ricke J; Bosiers M; Tepe G; Naisbitt S; Rosenfield K
JACC Cardiovasc Interv; 2014 Jan; 7(1):10-9. PubMed ID: 24456716
[TBL] [Abstract][Full Text] [Related]
35. 12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment.
Steiner S; Willfort-Ehringer A; Sievert H; Geist V; Lichtenberg M; Del Giudice C; Sauguet A; Diaz-Cartelle J; Marx C; Ströbel A; Schult I; Scheinert D;
JACC Cardiovasc Interv; 2018 May; 11(10):934-941. PubMed ID: 29730375
[TBL] [Abstract][Full Text] [Related]
36. Six-Month Outcomes From the First-in-Human, Single-Arm SELUTION Sustained-Limus-Release Drug-Eluting Balloon Trial in Femoropopliteal Lesions.
Zeller T; Brechtel K; Meyer DR; Noory E; Beschorner U; Albrecht T
J Endovasc Ther; 2020 Oct; 27(5):683-690. PubMed ID: 32666871
[No Abstract] [Full Text] [Related]
37. Primary Self-EXPANDing Nitinol Stenting vs Balloon Angioplasty With Optional Bailout Stenting for the Treatment of Infrapopliteal Artery Disease in Patients With Severe Intermittent Claudication or Critical Limb Ischemia (EXPAND Study).
Schulte KL; Pilger E; Schellong S; Tan KT; Baumann F; Langhoff R; Torsello G; Zeller T; Amendt K; Brodmann M;
J Endovasc Ther; 2015 Oct; 22(5):690-7. PubMed ID: 26245919
[TBL] [Abstract][Full Text] [Related]
38. Vessel Preparation in Infrapopliteal Arterial Disease: A Systematic Review and Meta-Analysis.
Nugteren MJ; Welling RHA; Bakker OJ; Ünlü Ç; Hazenberg CEVB
J Endovasc Ther; 2024 Apr; 31(2):191-202. PubMed ID: 36062761
[TBL] [Abstract][Full Text] [Related]
39. A Network Meta-analysis of Randomized Controlled Trials Comparing Treatment Modalities for Infrapopliteal Lesions in Critical Limb Ischemia.
Zhou Y; Lin S; Zhang Z; Xiao J; Ai W; Wang J; Li Y; Li Q
Ann Vasc Surg; 2019 Oct; 60():424-434. PubMed ID: 31075473
[TBL] [Abstract][Full Text] [Related]
40. Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia.
Hsu CC; Kwan GN; Singh D; Rophael JA; Anthony C; van Driel ML
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009195. PubMed ID: 30536919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
